Background Krebs von den Lungen-6 (KL-6) is a known biomarker for diagnosis and
monitoring of interstitial lung diseases. However, the role of serum KL-6 and the mucin 1 …

This article comprehensively elucidates the discovery of Krebs von den Lungen-6 (KL-6), its
structural features, functional mechanisms, and the current research status in various …

Background: The COVID-19 pandemic caused by SARS-CoV-2 continues to pose a
significant threat worldwide, with severe cases leading to hospitalization and death. This …

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)-infection is associated
with an extremely variable disease course. When interstitial pneumonia (IP) occurs, it can …

Abstract Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial
lung disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

Background Novel progressive fibrotic phenotype has recently been proposed characterized
by progressive and inexorable worsening of the disease. Krebs von den Lungen-6 (KL-6) …

Backgrounds To discern the potential of KL-6 and CA-153 as diagnostic tools for interstitial
lung disease (ILD), understand their relationship with GAP (Gender, Age, and Physiology) …

COVID-19 is the syndrome caused by SARS-CoV-2 infection. Severe phenotypes seem to
be caused by a “cytokines storm” and pneumonia is one of the most important clinical …